T1	Concept 53 61	SARS-CoV
T2	Concept 81 86	HIV-1
T3	Concept 96 106	inhibitors
T4	Concept 87 95	protease
T5	Concept 115 124	lopinavir
T6	Concept 129 138	ritonavir
T7	Concept 44 49	M pro
T9	Concept 30 35	drugs
R1	has-part Arg1:T1 Arg2:T7	
T10	Action 66 76	identified
A1	Uncertain T10
R2	in-context Arg1:T3 Arg2:T4	
R3	has-part Arg1:T2 Arg2:T4	
R4	is-a Arg1:T5 Arg2:T3	
R5	is-a Arg1:T6 Arg2:T3	
R6	target Arg1:T10 Arg2:T5	
R7	target Arg1:T10 Arg2:T6	
R8	in-context Arg1:T9 Arg2:T7	
R9	in-context Arg1:T10 Arg2:T9	
T8	Concept 258 262	data
T11	Concept 245 257	experimental
R10	has-property Arg1:T8 Arg2:T11	
T12	Concept 235 244	available
R11	has-property Arg1:T8 Arg2:T12	
T13	Concept 266 274	SARS-CoV
T14	Concept 275 283	protease
T15	Concept 284 294	inhibitors
R12	has-part Arg1:T13 Arg2:T14	
R13	in-context Arg1:T15 Arg2:T14	
R14	in-context Arg1:T8 Arg2:T15	
T16	Action 302 306	used
A2	Uncertain T16
T17	Action 330 338	generate
T18	Concept 343 353	inhibitors
T19	Concept 339 342	new
R15	has-property Arg1:T18 Arg2:T19	
T20	Concept 357 366	2019-nCoV
T21	Concept 367 375	protease
R16	has-part Arg1:T20 Arg2:T21	
R17	in-context Arg1:T18 Arg2:T21	
R18	target Arg1:T17 Arg2:T18	
R19	target Arg1:T16 Arg2:T17	
R20	subject Arg1:T16 Arg2:T8	
T22	Reference 404 409	model
T23	Concept 391 403	mathematical
R21	has-property Arg1:T22 Arg2:T23	
T24	Action 488 494	detect
A3	Uncertain T24
T25	Concept 495 499	1.15
T26	Concept 500 506	copies
T28	Concept 523 526	95%
T29	Concept 527 538	probability
T30	Concept 458 468	SARS-CoV-2
T31	Concept 478 483	panel
T32	Concept 469 477	designed
R22	has-property Arg1:T31 Arg2:T32	
R23	in-context Arg1:T31 Arg2:T30	
R24	subject Arg1:T24 Arg2:T31	
R25	target Arg1:T24 Arg2:T25	
R26	in-context Arg1:T25 Arg2:T26	
R27	has-property Arg1:T24 Arg2:T28	
R28	in-context Arg1:T28 Arg2:T29	
R29	in-context Arg1:T26 Arg2:T30	
R30	in-context Arg1:T24 Arg2:T22	
T27	Concept 584 591	binding
T33	Concept 592 598	energy
R31	has-property Arg1:T33 Arg2:T27	
T34	Concept 607 616	interface
T35	Concept 617 625	sequence
R32	has-property Arg1:T35 Arg2:T34	
T36	Concept 629 639	SARS-CoV-2
T37	Action 652 658	closer
T38	Concept 662 670	SARS-CoV
T39	Action 671 678	related
T40	Concept 679 687	isolates
T41	Concept 701 706	Human
T42	Concept 710 715	other
T43	Concept 720 727	species
R33	in-context Arg1:T42 Arg2:T43	
R34	has-part Arg1:T36 Arg2:T35	
R35	has-part Arg1:T36 Arg2:T33	
R36	subject Arg1:T37 Arg2:T35	
R37	subject Arg1:T37 Arg2:T33	
R38	subject Arg1:T39 Arg2:T40	
R39	target Arg1:T39 Arg2:T38	
R40	target Arg1:T37 Arg2:T40	
R41	in-place Arg1:T37 Arg2:T41	
R42	in-place Arg1:T37 Arg2:T42	
T44	Concept 733 741	SARS-CoV
T45	Concept 743 747	K929
T46	Concept 751 754	HR1
T47	Concept 764 769	E1163
T48	Concept 773 776	HR2
T49	Concept 787 791	salt
T50	Concept 792 798	bridge
T51	Concept 828 832	T925
T52	Action 840 848	involved
A4	Negated T52
T53	Concept 856 867	interaction
T54	Concept 799 808	214 3.2 Ã…
T55	Concept 812 820	distance
R43	has-property Arg1:T50 Arg2:T49	
R44	in-place Arg1:T45 Arg2:T46	
T56	Action 755 760	binds
R45	in-place Arg1:T47 Arg2:T48	
R46	subject Arg1:T56 Arg2:T45	
R47	target Arg1:T56 Arg2:T47	
R48	in-place Arg1:T56 Arg2:T44	
R49	has-property Arg1:T50 Arg2:T54	
R50	in-context Arg1:T54 Arg2:T55	
R51	in-context Arg1:T54 Arg2:T55	
R52	in-context Arg1:T56 Arg2:T50	
R53	subject Arg1:T52 Arg2:T51	
R54	target Arg1:T52 Arg2:T53	
R55	in-context Arg1:T53 Arg2:T56	
